Globalisation on pause? How scaleups can navigate today's uncertainty9:30 am - 10:30 am
Pathfinder Medical is developing a novel electronic guidance system that will enable clinicians to connect blood vessels in a minimally invasive way.
This platform technology can provide a safer, more reliable way for patients to receive haemodialysis or bypass arterial blockages. Worldwide, these unmet clinical needs represent a £4.2 billion yearly available market
There are over three million dialysis patients worldwide and every year patients undergo nearly 650,000 surgical AVF creation procedures. However, these procedures take a long time to heal and are prone to failure. Our technology has the power to significantly improve the outcomes for dialysis patients, improving their quality of life and saving millions of pounds in the process. We are delighted to have the support of BGF and Parkwalk to help the business move forward with our clinical trials and ultimately roll-out this ground-breaking product to a global market.Sorin Popa, CEO
Business funding insights
A post-exit perspective—with Leigh Howarth, CEO of STATS Group
In August, we announced the successful exit of our investment in STATS Group, an Aberdeen-based pipeline technology specialist for the global energy…
How BGF is helping companies to expand internationally: Elvie & OSL
BGF can support your business to expand overseas, just as we did with fast-growing femtech company Elvie and counter-drone tech business OSL. Read the case studies to learn more.